Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

restores lasting killing ability in

The hypothesis says repeated deformation restores killing capacity. Sustained gains after conditioning and , plus immune benefit from when practical support is matched, would distinguish it from improved care delivery.

Omega Point 1.2

Stage of verification

  1. Hypothesis published2026-09-21
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionImmune system

Biological function

Natural killer cells provide cytotoxic immune surveillance by killing susceptible target cells, including those lacking normal self-recognition signals, while sparing healthy cells of the same individual. This activity involves organizing the cortical cytoskeleton and directing cytolytic granules toward the target.Natural killer cell surveillance

Direction

Lens

Puts the cause in the physical arrangement: what is built where, how stiff it is, and what connects to what.Structure and topology

Kind of knowledge gap

The available measurement is only an indirect stand-in for what matters.Proxy gap

A double ring marks the main placement where a group contains several values.

Goal
Repeated-Demand Recovery Impairment and Surveillance Interruption Resistance
Competing hypotheses
1
Published
2026-09-21
Engine version
Omega Point 1.2
As a hypothesis
8 / 10Clarity of mechanism
7 / 10Few extra conditions
9 / 10Completeness of the answer
6 / 10Novelty of the idea
10 / 10Few new entities
8 / 10Decisive experiment
3 / 10Silver-bullet potential
4 / 10Support from research

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Immune cell

    Immune cells with cytotoxic activity that contribute to immune

    Where this hypothesis actsCirculating, surviving with impaired despite recovered mobility

    Hypotheses on this target 1
    NK cellsActivation. Hypotheses on this target 11Clearance restoration. Hypotheses on this target 0Reprogramming. Hypotheses on this target 0Adoptive transfer. Hypotheses on this target 0Elimination. Hypotheses on this target 0Immunosuppression. Hypotheses on this target 0Population balance. Hypotheses on this target 0
    • Activation1
    • Clearance restoration
    • Reprogramming
    • Adoptive transfer
    • Elimination
    • Immunosuppression
    • Population balance

    What is proposed

    Activation

    Restore through

    With whatPhysical or surgical intervention

    HowPatterned would cyclically deform , reversibly reorganizing their and

    Possible result

    Possible sustained improvement in and faster recovery of

    From the recordRepeated deformation of circulating NK cells during muscular activity supplies a ligand-independent mechanical licensing input that restores subsequent cytotoxic competence.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesInterleukin-11. Hypotheses on this target 5Interleukin-11Antibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGenotoxic microbial toxins. Hypotheses on this target 1Genotoxic microbial toxinsGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHeme-associated iron. Hypotheses on this target 1Heme-associated ironHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNT
GenesRetroelements. Hypotheses on this target 3RetroelementsExtrachromosomal DNA. Hypotheses on this target 2Extrachromosomal DNAAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesGenomic alterations. Hypotheses on this target 1Genomic alterationsHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p300PCMT1. Hypotheses on this target 2PCMT1TIM-4. Hypotheses on this target 2TIM-412-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIContractile proteins. Hypotheses on this target 1Contractile proteinsDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenasegp130. Hypotheses on this target 1gp130HCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2IL-11 receptor alpha. Hypotheses on this target 1IL-11 receptor alphaInterleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6Talin. Hypotheses on this target 1TalinTLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKα
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsT cells. Hypotheses on this target 4T cellsEpithelial cells. Hypotheses on this target 3Epithelial cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueDamaged cells. Hypotheses on this target 2Damaged cellsMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsApoptotic bodies. Hypotheses on this target 1Apoptotic bodiesBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cellsNK cells. Hypotheses on this target 1NK cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkConnective tissue. Hypotheses on this target 2Connective tissueSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCell-surface macromolecular brush. Hypotheses on this target 1Cell-surface macromolecular brushCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressExtracellular matrix mechanics. Hypotheses on this target 1Extracellular matrix mechanicsHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsMuscle fiber architecture. Hypotheses on this target 1Muscle fiber architectureSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 9EfferocytosisEpithelial barrier repair. Hypotheses on this target 7Epithelial barrier repairLipid peroxidation. Hypotheses on this target 7Lipid peroxidationSensory afferent activity. Hypotheses on this target 7Sensory afferent activityProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 5Calcium phosphate mineral growthInflammatory response. Hypotheses on this target 5Inflammatory responseTissue renewal timing. Hypotheses on this target 5Tissue renewal timingAntigen presentation. Hypotheses on this target 4Antigen presentationAntigen-receptor signaling. Hypotheses on this target 4Antigen-receptor signalingInflammation resolution. Hypotheses on this target 4Inflammation resolutionVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentDNA repair. Hypotheses on this target 2DNA repairEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationMechanical loading. Hypotheses on this target 2Mechanical loadingOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTranscription. Hypotheses on this target 2TranscriptionTranscription–replication conflicts. Hypotheses on this target 2Transcription–replication conflictsTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportUbiquitin-dependent proteasomal degradation. Hypotheses on this target 2Ubiquitin-dependent proteasomal degradationAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCardiovascular feedback regulation. Hypotheses on this target 1Cardiovascular feedback regulationCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle alignment. Hypotheses on this target 1Cell-cycle alignmentCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell-cycle restraint coordination. Hypotheses on this target 1Cell-cycle restraint coordinationCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentriole duplication. Hypotheses on this target 1Centriole duplicationCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCortisol inactivation. Hypotheses on this target 1Cortisol inactivationCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHeterotypic cell replacement. Hypotheses on this target 1Heterotypic cell replacementHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLactate-to-glucose recycling. Hypotheses on this target 1Lactate-to-glucose recyclingLipid-dependent receptor signaling. Hypotheses on this target 1Lipid-dependent receptor signalingLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal exocytosis. Hypotheses on this target 1Lysosomal exocytosisLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkNuclear-envelope rupture. Hypotheses on this target 1Nuclear-envelope ruptureNuclear rejuvenation. Hypotheses on this target 1Nuclear rejuvenationNutrient uptake and metabolism. Hypotheses on this target 1Nutrient uptake and metabolismOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismOxygen delivery. Hypotheses on this target 1Oxygen deliveryParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPathogen production. Hypotheses on this target 1Pathogen productionPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPotassium uptake. Hypotheses on this target 1Potassium uptakePreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRepair-initiation signaling. Hypotheses on this target 1Repair-initiation signalingRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSodium reabsorption. Hypotheses on this target 1Sodium reabsorptionSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstruction
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Regaining the ability to walk may not mean regaining the ability to fight disease. The unexpected move is to propose that movement physically conditions individual immune cells, leaving them better able to kill later, independently of improved access to meals, medication and care. That lasting cellular effect is a proposal generated by the pipeline, not a measured result established by the supplied material.

The proposed mechanism, link by link
  1. Muscular activity is proposed to repeatedly deform circulating in blood.
  2. Physical deformation is proposed to prepare the cells for later killing without requiring a signaling molecule to bind a .
  3. That input is proposed to reorganize the supporting structure beneath the cell surface and the machinery that directs killing packets toward a .
  4. Initially weakly responsive surviving cells are predicted to become persistently stronger killers, even after the stops.
  5. If these cells are the slowest part of immune recovery, appropriately patterned movement is predicted to improve recovery even when delivered meals, medication and care are equal.
A picture for it

A stiff folding tool might become easier to open after repeated flexing, and remain easier to use after the flexing stops.

Where the picture breaks: An immune cell is a living system that senses and responds to forces. The picture does not establish that movement supplies the required forces or that repeated deformation improves rather than impairs killing.

  1. Master questionstep 01 of 04

    Lasting immune recovery in older people must restore both rapid, broadly acting defenses and defenses that recognize particular threats, while retaining protection from past encounters, avoiding attacks on the body's own tissues, and keeping dormant infections controlled.

    Rests on: The goal defines recovery as several protective functions restored together and maintained over time.

    Stated in the chain
  2. Goal pillarstep 02 of 04

    Immune recovery must withstand repeated demands and interruptions to the body's watch for threats.

    Rests on: The master question requires durable protection and continued control of dormant infections.

    Stated in the chain
  3. Gap questionstep 03 of 04

    Walking ability and immune recovery may come apart, and any immune benefit from restored movement could come either directly from movement or indirectly through meals, medication and care.

    Rests on: The preceding pillar identifies resilience under repeated demands but supplies no account connecting that resilience to movement or practical support.

    Leap

    The bridge from resistance to repeated demands and interruptions to the specific mobility-versus-care distinction is not supplied.

  4. Hypothesisstep 04 of 04

    Repeated physical deformation during movement is proposed to leave surviving better able to kill later. The proposed change reorganizes their internal supporting structure and the machinery that directs packets of killing material toward a ; restored strength alone would not establish that this conditioning occurred.

    Rests on: The gap question explicitly opens a direct movement-to-immunity route that must be distinguished from improved practical support. The endpoint supplies a proposed cellular mechanism for that route, rather than reporting it as established.

    Stated in the chain

What is carried, and what is not. The supplied sources support neighboring observations, not the proposed sequence: S5, an abstract from review in 2021, reports improved natural killer cell function after exercise but does not identify physical deformation as the cause; S2, an abstract from Advanced materials in 2025, reports enhanced killing with ultrasound-activated particles but does not establish lasting conditioning from muscular activity. Neither source establishes the proposed mechanism end to end, and the supplied screening does not establish any complete link from ordinary movement through lasting cellular conditioning to durable immune recovery.S5S2

Where the reasoning is carried by something unstated · 1
  • Gap question. The bridge from resistance to repeated demands and interruptions to the specific mobility-versus-care distinction is not supplied. Establish the missing link before relying on this step.
How a result here could mislead · 3
  • Greater killing after conditioning could reflect a changed surrounding fluid or easier-to-kill rather than lasting improvement within the conditioned cells. S8, Brain, behavior, and immunity, 2018, reports an exercise-recovery effect associated with , the liquid remaining after blood clots, but does not test lasting ; S10, Scientific reports, 2021, attributes improved killing in its laboratory system to altered tumor , not stronger .S8S10 What closes it: The proposed removal of conditioning materials and use of identical untreated must be verified, including equal . Testing transfer of the surrounding fluid must distinguish a transferable effect from one retained by the cells.
  • A higher average killing rate could arise because stronger killers survived or multiplied, rather than because initially weak cells improved. What closes it: The stated exclusions of cell division, and changes in cell-group proportions require direct measurements. Tracking individual cells before and after conditioning must establish improvement in the initially weakly responsive cells.
  • A laboratory benefit could be credited to ordinary movement without establishing that movement delivers the same physical exposure; a negative clinical result could likewise reflect failure to deliver that exposure. What closes it: The forces produced during movement must be measured and reproduced in conditioning, and delivery of the relevant exposure must be established in the clinical test. Delivered practical support must also be verified as equal. The input leaves undefined, so its meaning, measurement and interpretation require specification before it can decide between explanations.

What would make this wrong. The central cellular claim would fail if initially weakly responsive cells showed no lasting increase in killing after verified under the stated conditions, with survival, division, surrounding-fluid effects and properties accounted for. A benefit explained entirely by delivered practical support would favor the supplied rival. Even a positive cellular result would leave the clinical chain broken if ordinary movement did not deliver the required physical exposure.

What it would change. If the proposal held, recovery of walking strength would be an inadequate stand-in for recovery of immune protection: the pattern of physical exposure reaching immune cells would also matter. Work on durable immune restoration would have to distinguish that exposure from movement's effects on delivered care. Even then, improved natural killer cell killing would not establish restoration of all the defenses in the master question, preservation of protection from past infections, avoidance of attacks on the body's own tissues, or long-term control of dormant infections.

Sources read · 7

3 literature searches, 8 full texts, 2 abstract-only; 10 source(s) read in full against this question. A bounded search is not evidence of absence.

S2Partly answers itAbstract only

Ultrasound-Activated Piezoelectric Nanoparticles Targeting and Activating NK Cells for Tumor Immunotherapy. · Advanced materials (Deerfield Beach, Fla.) · 2025

“With external ultrasonic stimulation, αCD56-P@BT or αNK1.1-P@BT can enhance the cytotoxicity and cytokine-producing ability of NK cells.”

Does not settle: This does not establish that repeated deformation during muscular activity provides ligand-independent, lasting mechanical licensing of circulating NK cells, nor that it restores granule polarization or changes SPV_10.

S5Partly answers itAbstract only

Exercise training effects on natural killer cells: a preliminary proteomics and systems biology approach. · Exercise immunology review · 2021

“A progressive exercise intervention of MICT followed by HIIT induces a remarkable improvement in NK function compared with the untrained state, although at the mechanistic level the pathways involved seem to differ over time during the intervention.”

Does not settle: This abstract reports increased NK cytotoxicity after an 8-week exercise intervention in eight healthy previously untrained adults, but does not establish that repeated cellular deformation during muscular activity is the cause, that licensing is ligand-independent, or that cortical cytoskeleton/granule-polarization changes mediate a lasting effect. It does not address NK surveillance as the slowest recovering domain, SPV_10, matched meals/medications/care access, or strength recovery.

S6Partly answers it

Natural killer cells from endurance-trained older adults show improved functional and metabolic responses to adrenergic blockade and mTOR inhibition. · Scientific reports · 2025

“With rapamycin, trained NK cells preserved NKG2D and CD107a at 10 ng/mL, maintaining cytotoxicity and degranulation.”

Does not settle: It does not test repeated mechanical deformation, ligand-independent licensing, cortical cytoskeletal or granule-polarization mechanisms, acute patterned mobilization, lasting restored killing in vivo, or effects on SPV_10 when meals, medication execution, and care access are matched.

S7Contradicts itQuote unverified

Chronic stimulation desensitizes β2-adrenergic receptor responses in natural killer cells. · European journal of immunology · 2024

“Additionally, epinephrine stimulation transiently reduced NK cell degranulation, serial killing, and cytokine production and affected metabolic changes upon NK cell activation via the cAMP-protein kinase A (PKA) pathway.”

Does not settle: This source does not test ligand-independent mechanical deformation, cortical cytoskeletal or granule-polarization reorganization, lasting restoration of cytotoxic competence, patterned mobilization, or SPV_10 in individuals.

S8Contradicts it

Autologous serum collected 1 h post-exercise enhances natural killer cell cytotoxicity. · Brain, behavior, and immunity · 2018

“Although exercise mobilized high-differentiated NK cell subsets (NKG2A-/KIR+), NKCA per cell was not altered post-exercise in the presence of pre-exercise serum.”

Does not settle: This source does not test repeated mechanical deformation, ligand-independent mechanical licensing, cortical cytoskeleton or granule-polarization mechanisms, lasting restoration of cytotoxic competence, or effects on NK-mediated surveillance and SPV_10. It instead reports a serum-associated effect during exercise recovery.

S9Background

Cytotoxic lymphocytes target characteristic biophysical vulnerabilities in cancer. · Immunity · 2021

“Immune synapses are physically active structures, exerting nanonewton scale mechanical forces that enhance the efficiency of perforin and granzyme-mediated killing”

Does not settle: This source text does not establish that repeated deformation during muscular activity mechanically licenses circulating NK cells, restores lasting later cytotoxic competence, reorganizes surviving NK-cell cortex or granule polarization, or shortens SPV_10 in people.

S10Contradicts it

Hypergravity-induced changes in actin response of breast cancer cells to natural killer cells. · Scientific reports · 2021

“we established the method improving responsiveness of target tumor cells (actin response positive MDA-MB-231) to the immune cells (NK cells) for efficient immunotherapy, not increasing the killing capacity of NK cells themselves in this study.”

Does not settle: This in-vitro hypergravity study does not establish mechanical licensing, lasting restored cytotoxic competence, cortical or granule-polarization changes in NK cells, effects of muscular activity or circulating NK cells, or effects on human surveillance or SPV_10.

The gap this hypothesis explains

What is measured here stands in for what matters, and may not track it.

Does restoring movement improve immune recovery directly, or through better access to food, medicines and care?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

When mobility recovers but immunity does not, does directly restore immune recovery capacity, or does its apparent benefit depend on restored access to meals, medication and care?

What this question is asking

The question concerns older people whose ability to move has recovered while their ability to recover immune function has not. It asks whether —helping someone resume movement—restores the immune system's own capacity to recover after a challenge, or whether any apparent benefit comes from improved access to meals, medication and care. The comparison is between an effect of movement itself and an effect explained by those improvements in access; both could also contribute. The question assumes that rehabilitation improves movement and physical , while those gains alone do not demonstrate immune recovery. Its wider aim is lasting recovery across immune function, movement, thinking and everyday participation without a continuing need for more assistance.

What the terms mean
Mobility
The ability to move around and carry out movement-dependent activities. Recovery of this ability is the physical change at the center of the question.
Mobilization
Helping someone resume movement. The supplied material does not specify a particular amount, intensity or program, and should not automatically be treated as equivalent to the long-term exercise discussed in S3.
Rehabilitation
Support intended to restore abilities needed for everyday life. The question assumes it improves movement, but the supplied sources do not establish the specific rehabilitation claim.
Physical reserve
Capacity available to cope with additional physical demands. It is a general concept here, not a specified measurement or threshold.
Immune system and immune function
The body's interacting defenses against infection and other threats, and the work those defenses perform. Immune function includes multiple activities, so improvement in one feature does not by itself describe the whole system.
Immune recovery capacity
The ability of immune functions to return after a challenge that disrupts them. The input does not specify the challenge, the measurements or the time allowed for recovery.
Immune surveillance
The immune system's detection of infections and other threats. Better physical performance is not itself a measurement of this activity.
Inflammation
A defensive response involved in responding to harm; persistent inflammation can also contribute to damage. Reducing it is not automatically equivalent to restoring all immune functions.
Age-related immune deterioration
Changes with aging that impair aspects of immune function. This describes a collection of changes rather than a single uniform condition.
Immune-cell features
Characteristics such as the activity or relative abundance of cells that perform immune functions. S3 reports changes in several such features, rather than directly answering the question about recovery after movement returns.
Direct effect and access pathway
A direct effect here means that movement affects immune recovery beyond changes in access to meals, medicines or care. The access pathway means that movement improves access to those supports, which then accounts for some or all of the immune benefit.
Association
A reported relationship between observations, such as exercise and immune features. It does not by itself establish that one caused the other.
Nutritional supplementation
Providing additional nutrients alongside usual food intake. S6 combines this with exercise, making their separate contributions difficult to determine.
Consensus process
A method for collecting and organizing agreement among participants. Considering a factor in such a process does not demonstrate that changing it causes recovery.
Dependence and participation
Dependence means needing assistance with activities or care; participation means being able to take part in everyday life. These are broader outcomes than movement alone.
What the question takes for granted
Premise not found in what was read
Rehabilitation improves mobility and ; strength and task performance do not establish immune recovery or .

Rehabilitation is support intended to restore everyday abilities, and physical is the capacity available to cope with additional demands. The question assumes that this support restores movement without necessarily restoring the immune system's ability to recover or detect threats. That distinction allows it to ask what, beyond moving better, explains any immune benefit.

The supplied search results do not establish this specific rehabilitation premise or document the stated pattern of recovered mobility with unrecovered immunity. S3 reports associations between long-term exercise and several immune features, but does not establish what happens when mobility returns. S6 reports difficulty separating exercise from nutritional supplementation and does not assess whether restored mobility restores immune recovery. These limitations leave the premise unestablished here; they do not show that it is false.S3S6

The same question asked without the part nothing read establishes:

  • In older people receiving help to resume movement, does immune recovery improve through movement itself, improved access to meals, medication and care, or both?
  • Does improved movement in older people coincide with improved immune recovery, and what explains any relationship?
What turns on the answer
  • Movement has a direct effect Under this outcome, resuming movement would improve the immune system's capacity to recover even without improvements in access to meals, medicines or care. Movement would therefore contribute something beyond making support easier to obtain, although the size and durability of that contribution would remain separate questions.
  • Benefit depends on improved access Under this outcome, restored movement would make meals, medicines or care more accessible, and those changes would account for the immune benefit. Improved movement without improved access would not establish the same benefit, and continued recovery could depend on maintaining that support.
  • Both pathways contribute Under this outcome, movement would affect immune recovery itself while also improving access to support that contributes to recovery. Attributing the entire benefit to either pathway would misstate what sustains it.
  • Immune recovery does not improve Under this outcome, movement could recover without a corresponding recovery of immune function. Better walking or task performance would then remain an inadequate basis for concluding that immune protection or independence had been restored.
Why it matters

The proposed pathways put different steps between movement and immune recovery. In the direct pathway, movement changes immune function and improves its recovery after a challenge. In the access pathway, movement makes food, medicines or care easier to obtain, and those changes support recovery. Treating improved movement as proof of immune recovery could therefore mistake better physical performance for restored protection. Conversely, attributing a benefit entirely to movement could conceal its dependence on continued access to essential support.

What is already established

RL-3 rehabilitation improves mobility and ; strength and task performance do not establish immune recovery or .

What would have to be true

Immune, physical, cognitive and participation functions return within separate without persistent lower plateaus or increasing dependence.

What is missing

Separate physiological recovery from improved care execution, and determine which prevents recurrent .

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

HERETICAL: Repeated deformation of circulating during muscular activity supplies a mechanical input that restores subsequent . The proposed substrate is reversible organization of the and in surviving . Restored walking ability can coexist with immune impairment because strength recovery does not establish that the necessary occurred. In individuals whose slowest recovering domain is , appropriately patterned would shorten even when meals, medication execution and care access are experimentally matched.

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

collected before acquire sustained, greater after in a conditioning apparatus, followed by and testing against identical untreated . The effect persists without cell division, , altered or , and occurs in initially cells lacking demonstrable . Disrupting during conditioning abolishes the later gain. In the , adds immune benefit despite verified equality of delivered practical support. Absence of durable conditioning, together with a support-only clinical benefit, favors IH_Q_L3_M_G4_4_02.

Would tell it apart from at least one rival. The prediction specifies observable functional gains, their abolition under an intervention, a clinical comparison under equal support, and an explicit alternative-favoring condition. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

, , and can test the cellular claim now. Conditioning must reproduce measured physiological forces and use identical downstream . Establishing that ordinary delivers the relevant is a separate necessary step; an effect alone would not establish the clinical mechanism.

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

collected before acquire sustained, greater after in a conditioning apparatus, followed by and testing against identical untreated . The effect persists without cell division, , altered or , and occurs in initially cells lacking demonstrable . Disrupting during conditioning abolishes the later gain. In the , adds immune benefit despite verified equality of delivered practical support. Absence of durable conditioning, together with a support-only clinical benefit, favors Mobility recovery helps immunity through completed care and continued support.

  • What would separate them

    Mobility recovery helps immunity through completed care and continued support predicts: Within the , an additional explicit task-ownership and recovery-status communication protocol versus equally resourced support organized around customary . remains available throughout. Among participants with comparable mobility gains, the explicit protocol prevents premature assistance withdrawal, increases verified completion of prescribed care and shortens immune recovery. The effect is by completed tasks and disappears when actual care delivery is already experimentally equalized. then adds no durable benefit. A persistent effect under matched execution, especially with , favors this hypothesis.

Why this is not the mainstream account

The engine is asked to say what its hypothesis would overturn and what would surprise a specialist. This is its answer.

Empirical anchor

Human form unstable contacts and fail to against soft artificial despite , demonstrating an unexpected mechanical dependence of execution. This supports mechanical sensitivity, not the proposed durable mechanism. [Primary experiment](https://pmc.ncbi.nlm.nih.gov/articles/PMC8077183/). Separately, mature mouse can reset responsiveness without dividing after transfer between environments, establishing that competence need not require cell replacement. [Joncker et al., 2010](https://pubmed.ncbi.nlm.nih.gov/20819928/).

Subfield revised

and . The textbook chapter ': , and ' would require a route to durable , rather than treating mechanics only as a modifier of .

Testable surprise

restores durable in initially mature while preserving sparing of healthy , with no encounter, or .

Why this is not the mainstream account

A targeted literature search identified established mechanical modulation during , but did not identify a review proposing that physiological, deformation substitutes for after the mechanical stimulus has ended. This is a bounded novelty check, not proof of universal literature absence. Ordinary is explicitly not the heretical claim.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionWould tell it apart from at least one rivalTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.